Fludrocortisone

7 trials 2 recruiting HEndocrinology

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

2 Recruiting

4 Completed trials

5 Sponsors

22 Countries

Phase III

Phase II

Phase I (Other)

Phase III: 5 Phase II: 1 Phase I (Other): 1

Oversight events:

27 temporary halts across 2 trials

View oversight register →

Indications tested

Prostate cancer metastatic 1 Pyoderma gangrenosum 1

Sponsors using this IMP

Merck Sharp & Dohme LLC 3 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire Amiens Picardie 1 Crinetics Pharmaceuticals Inc. 1 InflaRx GmbH 1

All trials

7 total

Prolonged corticosteroid therapy in scheduled cardiac surgery in intermediate/high-risk patients: a prospective multicenter randomized contr… Pending

2024-517699-39-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
A clinical study of opevesostat and standard hormone therapy in people with prostate cancer (MK-5684-004) Recruiting

2023-504957-11-00 Phase III 15 countries Merck Sharp & Dohme LLC
A clinical trial comparing a new treatment (MK-5684) to approved medication for advanced prostate cancer after prior hormonal therapy and ch… Recruiting

2023-504899-25-00 Phase III 14 countries Merck Sharp & Dohme LLC
A randomized, double-blind, placebo-controlled, multicenter, adaptive phase III trial to investigate the efficacy and safety of vilobelimab … Ended

2023-506250-20-00 Phase III 8 countries InflaRx GmbH
Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants with Congenital Adrenal Hyperplasia Ended

2023-503488-40-00 Phase II 2 countries Crinetics Pharmaceuticals Inc.
MK-5684 Food Effect Study Ended

2023-505521-14-00 Phase I (Other) 1 country Merck Sharp & Dohme LLC
Rapid rEcognition of COrticosteroid Resistant or sentive Sepsis - RECORDS Ended

2024-516407-16-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–7 of 7 trials

← All drugs A–Z